According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Foundation’s Vision Grant Program fund medical research pertaining to the pathophysiology, diagnosis, and treatment of hypertensive disorders of pregnancy.
The Preeclampsia Foundation, through the generous support of our donors, corporate partnerships, and community events such as The Promise Walk for Preeclampsia, has supported more than $550,000 in research since its founding in 2000. Successful projects have, in turn, garnered additional research support from major funding organizations, earned scientific merit at important meetings, and inspired young investigators to commit their life’s work to this complex field of study.
On February 13, 2019, the Preeclampsia Foundation announced at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Meeting that applications are now being accepted for its 2019 Vision Grant program.
The Preeclampsia Foundation will award up to two medical research Vision Grants to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 USD each. The Foundation’s Canadian affiliate, Preeclampsia Foundation Canada, will also award one Vision Grant up to $20,000 CAD, to a Canadian researcher.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows or Early Stage Investigators only are eligible to apply. Projects with the potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English.
Please note: The application period is closed and we are not currently accepting applications.
Answers to our most frequently asked questions about the registry
Everyone can play a role in preeclampsia research. Enroll Today login
The Preeclampsia Registry is a valuable resource that you can turn to when posing new questions, testing new hypotheses, and building study cohorts. As a “living database” that i...
The Letter of Intent period is CLOSED for the 2020 Peter Joseph Pappas Research Grants funding program. Decisions will be rendered in December 2020 and the next funding round will be announced next ye...
RESEARCH FUNDING Peter Joseph Pappas Research Grant Program March 3, 2021 - The 2021 funding season has closed and awardees have been announced. The call for 2022 Letters of Intent will be annou...
2021 Recipients Multi-omics for precision medicine in preeclampsia Principal Investigator: Kathryn J. Gray, MD, PhD Harvard Medical School and Massachusetts General Hospital (The General Hospital Co...
High Blood Pressure During Pregnancy May Be a Warning Sign of Life-threatening Condition World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and M...
Melbourne, FL – December 30, 2020 – The Preeclampsia Foundation announces the recipients of its 2021 Peter Joseph Pappas Research Grants, a funding program designed to accelerate p...
Title: Vitamin D in the womb may be protective for babies born from pregnancies complicated by preeclampsia Article Title: Associations of Cord Blood Vitamin D and Preeclampsia With Offspring B...
August 6, 2020 – Melbourne, FL – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia r...